Medical device capable of being compacted and expanded having anti-thrombin III binding activity
First Claim
Patent Images
1. A medical device comprising:
- a medical device that is capable of being compacted and expanded;
a fluoropolymeric substrate material;
a plurality of layers of a polymeric covering material attached to at least a portion of a surface of said substrate material and cross-linked, a biologically active substance having anti-thrombin III binding activity of at least 5 picomoles per square centimeter (pmol/cm2) of substrate material covalently attached to at least a portion of said layers of said polymeric covering material; and
a biologically compatible glycosaminoglycan non-covalently combined with said polymeric covering material and said biologically active substance,wherein said biologically active substance has an anti-thrombin III binding activity of at least 5 picomoles anti-thrombin III per square centimeter (pmol/cm2) substrate material when measured following compaction of said medical device to 50% of said medical device'"'"'s original size and expansion of said medical device.
2 Assignments
0 Petitions
Accused Products
Abstract
The present invention relates to immobilized biologically active entities that retain significant biological activity following mechanical manipulation of a substrate material to which the entities are immobilized.
88 Citations
26 Claims
-
1. A medical device comprising:
-
a medical device that is capable of being compacted and expanded; a fluoropolymeric substrate material; a plurality of layers of a polymeric covering material attached to at least a portion of a surface of said substrate material and cross-linked, a biologically active substance having anti-thrombin III binding activity of at least 5 picomoles per square centimeter (pmol/cm2) of substrate material covalently attached to at least a portion of said layers of said polymeric covering material; and a biologically compatible glycosaminoglycan non-covalently combined with said polymeric covering material and said biologically active substance, wherein said biologically active substance has an anti-thrombin III binding activity of at least 5 picomoles anti-thrombin III per square centimeter (pmol/cm2) substrate material when measured following compaction of said medical device to 50% of said medical device'"'"'s original size and expansion of said medical device. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26)
-
Specification